Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-026838

Chief Executive Officer sold 8,800 shares at an average $42.46 ($373,659)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ciechanover Isaac E. Chief Executive Officer 2018-04-26 Sale −3,300 $41.99 $138,567 194,378 I: show line 1 in the form
Ciechanover Isaac E. Chief Executive Officer 2018-04-26 Sale −1,100 $42.60 $46,860 193,278 I: show line 2 in the form
Ciechanover Isaac E. Chief Executive Officer 2018-04-27 Sale −3,900 $42.63 $166,257 189,378 I: show line 3 in the form
Ciechanover Isaac E. Chief Executive Officer 2018-04-27 Sale −500 $43.95 $21,975 188,878 I: show line 4 in the form
Open-market sales · 8,800 sh · avg $42.46 · $373,659
Loading xslF345X03/doc4.xml…